Difference between revisions of "Reactive changes"

From Libre Pathology
Jump to navigation Jump to search
Line 17: Line 17:
==Microscopic==
==Microscopic==
Features - generic:
Features - generic:
*Nuclear changes:
*Nuclear changes - typically:
**Nuclear enlargement.
**Nuclear enlargement.
**Nuclear hyperchromasia.
**Nuclear hyperchromasia.
**Prominent nucleoli.
**Prominent nucleoli.
*Inflammation - acute and/or chronic.
*Inflammation - any type (e.g. [[neutrophil|neutrophilic]], [[plasma cells|plasmacytic]], lymphoplasmacytic).
**Typically intraepithelial inflammatory cells.


DDx:
DDx:

Revision as of 07:09, 31 December 2014

Reactive changes is a commonly used term that implies:

  1. Inflammation.
  2. Nuclear changes compatible with inflammation.

General

Nuclear changes are seen in:

  • Inflammatory processes.
  • Repair.
  • Neoplastic processes.

Significance of nuclear changes in inflammation:

  • The line between a reactive process and a neoplastic process may be fuzzy.

Consequence:

  • In the context of inflammation, nuclear changes are typically present and the threshold for calling suspicious or malignancy is typically higher.

Microscopic

Features - generic:

  • Nuclear changes - typically:
    • Nuclear enlargement.
    • Nuclear hyperchromasia.
    • Prominent nucleoli.
  • Inflammation - any type (e.g. neutrophilic, plasmacytic, lymphoplasmacytic).
    • Typically intraepithelial inflammatory cells.

DDx:

  • Waffle diagnosis (e.g. indefinite for dysplasia) - nuclear changes of unknown significance.
    • Terminology dependent on the anatomical site.
  • Nuclear atypia.
    • This is often qualified as it may represent neoplastic process or a benign process dependent on the context.
    • Common qualifiers:
      • Worrisome lesions: "cannot exclude dysplasia", "suspicious for malignancy".
      • Suspected to be benign: "favour benign".
  • Malignancy.

See also